Cannabis Science to feature in two broadcast radio shows

Cannabis Science Inc. (NASD OTCBB: CBIS) an emerging pharmaceutical cannabis company, is pleased to report that it will be featured on two broadcast radio shows beginning tomorrow with Stu Taylor and the “Equity Strategies Show”. Mr. Taylor will interview Cannabis Science Inc., President & CEO, Dr. Robert Melamede Ph.D., discussing the Company’s strategies with its FDA Drug approval programs, the Company’s progress to date with its critical drug release programs, and future planning for subsequent drug releases through additional Federal and State government agencies.

Stu Taylor is a well renowned talk show host and currently hosts three business radio shows: Equity Strategies on the Business Talk Radio Network, Equity Strategies on the Radio America Network, and Stu Taylor on Business, aired on WBIX-AM (1060), Boston. Mr. Taylor is also a contributor to television’s Fox Business Network.

Listeners can tune into Stu Taylor and Dr. Melamede’s initial discussion airing Wednesday the 23rd of September at 8:06am Eastern on WBIX 1060 AM. The show starts at 8am Eastern, covering the New England States of Maine, Vermont, New Hampshire, Massachusetts, Rhode Island, and Connecticut. You can also go to www.WBIX.com and listen to the broadcast or download the stream for future reference.

The second interview with Stu Taylor and Dr. Melamede will be aired on Saturday the 26th of September at 9pm Eastern covering 32 different cities spread across the Nation. The show will air on 32 different Radio Stations within the Business Talk Radio Network, which will be simulcast on www.BusinessTalkRadio.net for listeners to tune in over the Internet as well.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Dronabinol shows promise in reducing agitation in Alzheimer's patients